Horowitz A, Chanez-Paredes S, Haest X, Turner J
Nat Rev Gastroenterol Hepatol. 2023; 20(7):417-432.
PMID: 37186118
PMC: 10127193.
DOI: 10.1038/s41575-023-00766-3.
Varesi A, Campagnoli L, Fahmideh F, Pierella E, Romeo M, Ricevuti G
Int J Mol Sci. 2022; 23(20).
PMID: 36293176
PMC: 9603886.
DOI: 10.3390/ijms232012289.
Yang H, Li S, Le W
Aging Dis. 2022; 13(5):1381-1390.
PMID: 36186124
PMC: 9466983.
DOI: 10.14336/AD.2022.01281.
Siebner T, Fuglsang S, Madelung C, Lokkegaard A, Bendtsen F, Hove J
Front Neurol. 2022; 13:828069.
PMID: 35280265
PMC: 8910363.
DOI: 10.3389/fneur.2022.828069.
Linetsky E, Abd Elhadi S, Bauer M, Gallant A, Namnah M, Weiss S
Front Neurol. 2022; 12:716126.
PMID: 35046880
PMC: 8761891.
DOI: 10.3389/fneur.2021.716126.
T cells, α-synuclein and Parkinson disease.
Garretti F, Monahan C, Sette A, Agalliu D, Sulzer D
Handb Clin Neurol. 2022; 184:439-455.
PMID: 35034753
PMC: 10193709.
DOI: 10.1016/B978-0-12-819410-2.00023-0.
Mediterranean Diet Adherence in People With Parkinson's Disease Reduces Constipation Symptoms and Changes Fecal Microbiota After a 5-Week Single-Arm Pilot Study.
Rusch C, Beke M, Tucciarone L, Nieves Jr C, Ukhanova M, Tagliamonte M
Front Neurol. 2022; 12:794640.
PMID: 35002935
PMC: 8733603.
DOI: 10.3389/fneur.2021.794640.
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?.
Blesa J, Foffani G, Dehay B, Bezard E, Obeso J
Nat Rev Neurosci. 2021; 23(2):115-128.
PMID: 34907352
DOI: 10.1038/s41583-021-00542-9.
Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson's Disease.
Danau A, Dumitrescu L, Lefter A, Tulba D, Popescu B
Int J Mol Sci. 2021; 22(21).
PMID: 34769091
PMC: 8584211.
DOI: 10.3390/ijms222111663.
What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease?.
Hill A, Wade-Martins R, Burnet P
Front Neurosci. 2021; 15:708587.
PMID: 34512244
PMC: 8432298.
DOI: 10.3389/fnins.2021.708587.
Association of small intestinal bacterial overgrowth with Parkinson's disease: a systematic review and meta-analysis.
Li X, Feng X, Jiang Z, Jiang Z
Gut Pathog. 2021; 13(1):25.
PMID: 33863370
PMC: 8051095.
DOI: 10.1186/s13099-021-00420-w.
Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives.
Kornum D, Terkelsen A, Bertoli D, Klinge M, Hoyer K, Kufaishi H
J Clin Med. 2021; 10(7).
PMID: 33807256
PMC: 8037288.
DOI: 10.3390/jcm10071392.
Gastrointestinal and metabolic function in the MPTP-treated macaque model of Parkinson's disease.
Delamarre A, MacSweeney C, Suzuki R, Brown A, Li Q, Pioli E
Heliyon. 2021; 6(12):e05771.
PMID: 33385085
PMC: 7772551.
DOI: 10.1016/j.heliyon.2020.e05771.
Gastrointestinal dysfunction in the synucleinopathies.
Chung K, Pfeiffer R
Clin Auton Res. 2020; 31(1):77-99.
PMID: 33247399
DOI: 10.1007/s10286-020-00745-7.
Autonomic Dysfunction in Parkinson's Disease.
Pfeiffer R
Neurotherapeutics. 2020; 17(4):1464-1479.
PMID: 32789741
PMC: 7851208.
DOI: 10.1007/s13311-020-00897-4.
Distinctive Pathophysiology Underlying Constipation in Parkinson's Disease: Implications for Cognitive Inefficiency.
Tucker R, Ryan S, Hayee B, Bjarnason I, Augustin A, Umamahesan C
J Clin Med. 2020; 9(6).
PMID: 32575365
PMC: 7356098.
DOI: 10.3390/jcm9061916.
The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge.
van Ijzendoorn S, Derkinderen P
J Parkinsons Dis. 2019; 9(s2):S323-S329.
PMID: 31561386
PMC: 6839484.
DOI: 10.3233/JPD-191707.
Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
Garretti F, Agalliu D, Arlehamn C, Sette A, Sulzer D
Front Immunol. 2019; 10:303.
PMID: 30858851
PMC: 6397885.
DOI: 10.3389/fimmu.2019.00303.
Imaging the Autonomic Nervous System in Parkinson's Disease.
Knudsen K, Borghammer P
Curr Neurol Neurosci Rep. 2018; 18(11):79.
PMID: 30232650
DOI: 10.1007/s11910-018-0889-4.
Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.
Fang X
Metab Brain Dis. 2018; 33(4):1031-1043.
PMID: 29681010
DOI: 10.1007/s11011-018-0239-x.